Clik here to view.
Avastin Gets Green Light for Use in Kidney Cancer
Image by Getty Images via Daylife Score another win for Genentech and its cancer treatment Avastin (bevacizumab). On Monday, the biotech giant, now owned entirely by Roche, announced that FDA has...
View ArticleClik here to view.
Advisory Panel Rejects Avastin For Breast Cancer Treatment
An FDA advisory panel on Tuesday voted 12–1 to discontinue Avastin (bevacizumab) as a treatment for advanced breast cancer due to post-market studies stating that the treatment does not to increase...
View ArticleIn the Absence of Avastin: New Opportunity
written by guest blogger Ed Kissel, Vice President of Quantitative Analysis In July 2010, an advisory panel voted 12-1 to urge the FDA to withdraw the approved use of Avastin in metastatic...
View ArticlePharm Exec's Brands of Yesteryear: Where Are They Now?
Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others. The US drug pricing wars may be coming, but these...
View ArticleClik here to view.
What Does ‘Off Label’ Mean in 2014?
by Tom Norton Years ago, while sitting in an Rx company lunch room, I was listening to one of the company’s top sales reps discuss the commercial progress a recently launched prescription was making....
View Article
